Microtest supports AIRC: research and innovation to beat cancer

The social influence of a company is represented not only by the turnover, but also through the ability to integrate itself into the community and make an effective contribution to improving people health and living conditions.
To give a concrete support to an important social issue, Microtest decided to sustain AIRC Foundation for Cancer Research in Italy.
Since 1965 AIRC’s mission is to understand, prevent and cure cancer through research carried out at University Laboratories, Hospitals and Scientific Institutes.

A relentless and tangible activity that is only possible thanks to millions of donors: Microtest is proud to be one of them.

“Innovation and research are the heart of our philosophy – says Giuseppe Amelio, CEO Microtest – we responsibly sustain AIRC in discovering innovative treatments in cancer prevention, diagnosis and therapy. We want to make our contribution to keep up the battle against cancer together”.

Microtest earmarked the Christmas 2019 donation for research to defeat pediatric cancers. In 2019, AIRC allocated over € 6 million to pediatric cancer research for around 70 projects and scholarships, with the aim of developing increasingly effective, personalized and less toxic therapies for young patients.